CN Stock MarketDetailed Quotes

600713 Nanjing Pharmaceutical

Watchlist
  • 5.03
  • +0.35+7.48%
Market Closed Sep 30 15:00 CST
6.59BMarket Cap11.35P/E (TTM)

Nanjing Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-0.41%27.23B
-0.92%13.95B
6.71%53.59B
8.31%40.55B
14.21%27.34B
20.35%14.08B
11.30%50.22B
12.09%37.44B
9.34%23.94B
5.56%11.7B
Operating revenue
-0.41%27.23B
-0.92%13.95B
6.71%53.59B
8.31%40.55B
14.21%27.34B
20.35%14.08B
11.30%50.22B
12.09%37.44B
9.34%23.94B
5.56%11.7B
Other operating revenue
44.29%60.72M
----
-21.15%116.29M
----
-43.56%42.08M
----
-7.30%147.48M
----
7.69%74.56M
----
Total operating cost
-0.65%26.67B
-1.15%13.66B
7.03%52.65B
8.59%39.81B
14.72%26.84B
20.73%13.82B
11.16%49.19B
12.01%36.66B
9.01%23.4B
5.24%11.45B
Operating cost
-0.60%25.55B
-1.18%13.11B
7.06%50.28B
8.57%38.08B
14.84%25.71B
20.93%13.27B
11.32%46.96B
12.28%35.08B
9.15%22.39B
5.19%10.97B
Operating tax surcharges
22.99%54.79M
23.25%25.45M
-7.69%107.59M
-11.87%73.71M
-16.41%44.55M
16.84%20.65M
27.57%116.55M
38.36%83.64M
48.44%53.29M
2.15%17.67M
Operating expense
-1.63%557.87M
-2.28%281.36M
1.34%1.17B
3.83%858.87M
8.22%567.14M
15.11%287.92M
7.58%1.16B
6.94%827.17M
3.43%524.08M
0.13%250.13M
Administration expense
-12.25%209.42M
-8.18%101.96M
6.24%517.44M
8.81%361.69M
8.70%238.65M
6.84%111.04M
12.50%487.05M
6.37%332.41M
14.85%219.55M
24.27%103.93M
Financial expense
0.71%269.71M
4.55%131.87M
22.88%534.75M
26.60%400.98M
32.04%267.79M
25.47%126.13M
-1.51%435.17M
-1.87%316.72M
-3.65%202.81M
8.42%100.52M
-Interest expense (Financial expense)
-9.63%170.53M
-3.64%88.83M
13.70%378.49M
14.72%288.55M
15.10%188.7M
5.86%92.19M
-12.44%332.9M
-10.84%251.53M
-7.72%163.94M
7.00%87.09M
-Interest Income (Financial expense)
-29.66%-6.4M
-3.24%-3.98M
11.16%-10.14M
23.15%-8.21M
27.17%-4.93M
16.74%-3.85M
13.38%-11.41M
-15.80%-10.68M
-3.10%-6.77M
-96.15%-4.63M
Research and development
24.52%22.29M
22.30%10.23M
31.91%36.19M
30.25%28.51M
32.68%17.9M
69.19%8.37M
30.90%27.43M
33.23%21.89M
29.67%13.49M
3.93%4.95M
Credit Impairment Loss
-449.11%-33.85M
-186.99%-36.26M
119.62%19.29M
66.47%-20.55M
123.77%9.7M
65.25%-12.64M
-1,131.86%-98.33M
-102.84%-61.29M
-122.00%-40.79M
-20.88%-36.36M
Asset Impairment Loss
-45.68%-4.92M
-139.08%-467.14K
7.72%-6.25M
-2,580.78%-3.94M
-2,761.32%-3.38M
-363.15%-195.39K
21.42%-6.77M
772.99%158.96K
-748.32%-118.05K
--74.25K
Other net revenue
-156.90%-19.64M
-247.88%-26.28M
162.58%63.22M
120.37%15.05M
152.66%34.51M
80.60%-7.55M
-256.68%-101.02M
7.97%-73.87M
-22.98%-65.53M
11.92%-38.93M
Invest income
-73.79%1.04M
114.08%105.36K
117.64%8.58M
117.85%8.71M
107.71%3.96M
96.87%-748.43K
44.56%-48.64M
25.33%-48.79M
-16.31%-51.36M
-37.36%-23.94M
-Including: Investment income associates
-78.58%834.34K
91.36%-64.64K
1,267.85%6.06M
4,047.13%6.25M
1,158.53%3.9M
-4,483.73%-748.43K
82.10%-519.05K
90.73%-158.44K
77.31%-368.02K
---16.33K
Asset deal income
2,122.50%4.04M
7,378.27%4.29M
-90.83%2.2M
-100.23%-52.3K
-98.99%181.66K
-100.33%-58.97K
-60.41%23.97M
420.25%22.61M
295.68%18M
906.89%17.84M
Other revenue
-41.53%14.06M
-0.51%6.05M
36.97%39.4M
129.76%30.89M
175.16%24.05M
76.14%6.08M
85.88%28.76M
23.09%13.44M
86.89%8.74M
125.65%3.45M
Operating profit
1.90%545.53M
4.52%263.54M
7.83%1.01B
7.17%754.69M
12.24%535.37M
18.56%252.13M
10.48%934.32M
19.44%704.2M
25.70%477M
31.18%212.66M
Add:Non operating Income
395.78%7.92M
1,100.45%3.62M
-68.17%2.57M
-31.79%2.37M
-49.15%1.6M
-79.72%301.59K
-52.50%8.06M
-55.64%3.48M
26.28%3.14M
59.12%1.49M
Less:Non operating expense
-18.70%12.56M
-33.08%4.95M
-12.18%31.94M
-1.98%24.89M
-17.27%15.45M
7.02%7.39M
52.71%36.37M
84.88%25.39M
113.95%18.67M
87.43%6.91M
Total profit
3.71%540.88M
7.01%262.22M
7.95%978.07M
7.31%732.18M
13.01%521.52M
18.24%245.04M
8.00%906.01M
16.89%682.29M
23.64%461.47M
30.05%207.24M
Less:Income tax cost
-1.64%143.34M
6.23%65.27M
39.54%265.26M
57.25%199.22M
104.29%145.73M
11.04%61.44M
-16.74%190.09M
-20.91%126.68M
-32.05%71.33M
28.07%55.33M
Net profit
5.79%397.54M
7.27%196.95M
-0.43%712.81M
-4.07%532.96M
-3.68%375.79M
20.86%183.61M
17.26%715.92M
31.19%555.61M
45.44%390.13M
30.78%151.91M
Net profit from continuing operation
5.79%397.54M
7.27%196.95M
-0.43%712.81M
-4.07%532.96M
-3.68%375.79M
20.86%183.61M
17.26%715.92M
31.19%555.61M
45.44%390.13M
30.78%151.91M
Less:Minority Profit
28.41%86.22M
9.92%37.86M
12.25%134.98M
8.55%92.67M
17.98%67.15M
77.93%34.45M
14.12%120.25M
10.62%85.37M
24.05%56.92M
36.33%19.36M
Net profit of parent company owners
0.87%311.32M
6.65%159.08M
-3.00%577.83M
-6.37%440.3M
-7.38%308.64M
12.53%149.16M
17.91%595.67M
35.78%470.24M
49.86%333.22M
30.01%132.55M
Earning per share
Basic earning per share
1.27%0.24
7.89%0.123
-6.32%0.445
-10.53%0.34
-14.13%0.237
1.79%0.114
-2.06%0.475
15.15%0.38
31.43%0.276
14.29%0.112
Diluted earning per share
1.27%0.24
7.89%0.123
-6.32%0.445
-10.53%0.34
-14.13%0.237
1.79%0.114
-2.06%0.475
15.15%0.38
31.43%0.276
14.29%0.112
Other composite income
-186.80%-7.7M
-135.62%-6.23M
113.97%7.54M
108.18%5.03M
125.46%8.87M
156.65%17.49M
-21.67%-53.96M
-12.84%-61.5M
26.70%-34.83M
6.44%-30.87M
Other composite income of parent company owners
-191.04%-8.11M
-134.36%-5.95M
114.72%7.75M
108.91%5.37M
124.96%8.91M
156.21%17.31M
-25.84%-52.65M
-18.07%-60.26M
20.08%-35.69M
9.35%-30.8M
Other composite income of minority owners
1,145.38%411.49K
-260.28%-281.13K
83.75%-212.41K
72.72%-338.93K
-104.61%-39.36K
335.03%175.4K
47.92%-1.31M
64.12%-1.24M
129.73%853.66K
-107.63%-74.63K
Total composite income
1.35%389.85M
-5.16%190.72M
8.82%720.35M
8.88%537.99M
8.26%384.66M
66.14%201.09M
16.91%661.96M
33.90%494.11M
60.97%355.3M
45.55%121.04M
Total composite income of parent company owners
-4.52%303.21M
-8.01%153.13M
7.84%585.57M
8.70%445.66M
6.73%317.55M
63.60%166.47M
17.20%543.02M
38.84%409.98M
67.43%297.53M
49.68%101.76M
Total composite income of minority owners
29.09%86.63M
8.55%37.58M
13.31%134.77M
9.76%92.33M
16.17%67.11M
79.53%34.62M
15.64%118.94M
14.13%84.12M
34.31%57.77M
27.06%19.28M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -0.41%27.23B-0.92%13.95B6.71%53.59B8.31%40.55B14.21%27.34B20.35%14.08B11.30%50.22B12.09%37.44B9.34%23.94B5.56%11.7B
Operating revenue -0.41%27.23B-0.92%13.95B6.71%53.59B8.31%40.55B14.21%27.34B20.35%14.08B11.30%50.22B12.09%37.44B9.34%23.94B5.56%11.7B
Other operating revenue 44.29%60.72M-----21.15%116.29M-----43.56%42.08M-----7.30%147.48M----7.69%74.56M----
Total operating cost -0.65%26.67B-1.15%13.66B7.03%52.65B8.59%39.81B14.72%26.84B20.73%13.82B11.16%49.19B12.01%36.66B9.01%23.4B5.24%11.45B
Operating cost -0.60%25.55B-1.18%13.11B7.06%50.28B8.57%38.08B14.84%25.71B20.93%13.27B11.32%46.96B12.28%35.08B9.15%22.39B5.19%10.97B
Operating tax surcharges 22.99%54.79M23.25%25.45M-7.69%107.59M-11.87%73.71M-16.41%44.55M16.84%20.65M27.57%116.55M38.36%83.64M48.44%53.29M2.15%17.67M
Operating expense -1.63%557.87M-2.28%281.36M1.34%1.17B3.83%858.87M8.22%567.14M15.11%287.92M7.58%1.16B6.94%827.17M3.43%524.08M0.13%250.13M
Administration expense -12.25%209.42M-8.18%101.96M6.24%517.44M8.81%361.69M8.70%238.65M6.84%111.04M12.50%487.05M6.37%332.41M14.85%219.55M24.27%103.93M
Financial expense 0.71%269.71M4.55%131.87M22.88%534.75M26.60%400.98M32.04%267.79M25.47%126.13M-1.51%435.17M-1.87%316.72M-3.65%202.81M8.42%100.52M
-Interest expense (Financial expense) -9.63%170.53M-3.64%88.83M13.70%378.49M14.72%288.55M15.10%188.7M5.86%92.19M-12.44%332.9M-10.84%251.53M-7.72%163.94M7.00%87.09M
-Interest Income (Financial expense) -29.66%-6.4M-3.24%-3.98M11.16%-10.14M23.15%-8.21M27.17%-4.93M16.74%-3.85M13.38%-11.41M-15.80%-10.68M-3.10%-6.77M-96.15%-4.63M
Research and development 24.52%22.29M22.30%10.23M31.91%36.19M30.25%28.51M32.68%17.9M69.19%8.37M30.90%27.43M33.23%21.89M29.67%13.49M3.93%4.95M
Credit Impairment Loss -449.11%-33.85M-186.99%-36.26M119.62%19.29M66.47%-20.55M123.77%9.7M65.25%-12.64M-1,131.86%-98.33M-102.84%-61.29M-122.00%-40.79M-20.88%-36.36M
Asset Impairment Loss -45.68%-4.92M-139.08%-467.14K7.72%-6.25M-2,580.78%-3.94M-2,761.32%-3.38M-363.15%-195.39K21.42%-6.77M772.99%158.96K-748.32%-118.05K--74.25K
Other net revenue -156.90%-19.64M-247.88%-26.28M162.58%63.22M120.37%15.05M152.66%34.51M80.60%-7.55M-256.68%-101.02M7.97%-73.87M-22.98%-65.53M11.92%-38.93M
Invest income -73.79%1.04M114.08%105.36K117.64%8.58M117.85%8.71M107.71%3.96M96.87%-748.43K44.56%-48.64M25.33%-48.79M-16.31%-51.36M-37.36%-23.94M
-Including: Investment income associates -78.58%834.34K91.36%-64.64K1,267.85%6.06M4,047.13%6.25M1,158.53%3.9M-4,483.73%-748.43K82.10%-519.05K90.73%-158.44K77.31%-368.02K---16.33K
Asset deal income 2,122.50%4.04M7,378.27%4.29M-90.83%2.2M-100.23%-52.3K-98.99%181.66K-100.33%-58.97K-60.41%23.97M420.25%22.61M295.68%18M906.89%17.84M
Other revenue -41.53%14.06M-0.51%6.05M36.97%39.4M129.76%30.89M175.16%24.05M76.14%6.08M85.88%28.76M23.09%13.44M86.89%8.74M125.65%3.45M
Operating profit 1.90%545.53M4.52%263.54M7.83%1.01B7.17%754.69M12.24%535.37M18.56%252.13M10.48%934.32M19.44%704.2M25.70%477M31.18%212.66M
Add:Non operating Income 395.78%7.92M1,100.45%3.62M-68.17%2.57M-31.79%2.37M-49.15%1.6M-79.72%301.59K-52.50%8.06M-55.64%3.48M26.28%3.14M59.12%1.49M
Less:Non operating expense -18.70%12.56M-33.08%4.95M-12.18%31.94M-1.98%24.89M-17.27%15.45M7.02%7.39M52.71%36.37M84.88%25.39M113.95%18.67M87.43%6.91M
Total profit 3.71%540.88M7.01%262.22M7.95%978.07M7.31%732.18M13.01%521.52M18.24%245.04M8.00%906.01M16.89%682.29M23.64%461.47M30.05%207.24M
Less:Income tax cost -1.64%143.34M6.23%65.27M39.54%265.26M57.25%199.22M104.29%145.73M11.04%61.44M-16.74%190.09M-20.91%126.68M-32.05%71.33M28.07%55.33M
Net profit 5.79%397.54M7.27%196.95M-0.43%712.81M-4.07%532.96M-3.68%375.79M20.86%183.61M17.26%715.92M31.19%555.61M45.44%390.13M30.78%151.91M
Net profit from continuing operation 5.79%397.54M7.27%196.95M-0.43%712.81M-4.07%532.96M-3.68%375.79M20.86%183.61M17.26%715.92M31.19%555.61M45.44%390.13M30.78%151.91M
Less:Minority Profit 28.41%86.22M9.92%37.86M12.25%134.98M8.55%92.67M17.98%67.15M77.93%34.45M14.12%120.25M10.62%85.37M24.05%56.92M36.33%19.36M
Net profit of parent company owners 0.87%311.32M6.65%159.08M-3.00%577.83M-6.37%440.3M-7.38%308.64M12.53%149.16M17.91%595.67M35.78%470.24M49.86%333.22M30.01%132.55M
Earning per share
Basic earning per share 1.27%0.247.89%0.123-6.32%0.445-10.53%0.34-14.13%0.2371.79%0.114-2.06%0.47515.15%0.3831.43%0.27614.29%0.112
Diluted earning per share 1.27%0.247.89%0.123-6.32%0.445-10.53%0.34-14.13%0.2371.79%0.114-2.06%0.47515.15%0.3831.43%0.27614.29%0.112
Other composite income -186.80%-7.7M-135.62%-6.23M113.97%7.54M108.18%5.03M125.46%8.87M156.65%17.49M-21.67%-53.96M-12.84%-61.5M26.70%-34.83M6.44%-30.87M
Other composite income of parent company owners -191.04%-8.11M-134.36%-5.95M114.72%7.75M108.91%5.37M124.96%8.91M156.21%17.31M-25.84%-52.65M-18.07%-60.26M20.08%-35.69M9.35%-30.8M
Other composite income of minority owners 1,145.38%411.49K-260.28%-281.13K83.75%-212.41K72.72%-338.93K-104.61%-39.36K335.03%175.4K47.92%-1.31M64.12%-1.24M129.73%853.66K-107.63%-74.63K
Total composite income 1.35%389.85M-5.16%190.72M8.82%720.35M8.88%537.99M8.26%384.66M66.14%201.09M16.91%661.96M33.90%494.11M60.97%355.3M45.55%121.04M
Total composite income of parent company owners -4.52%303.21M-8.01%153.13M7.84%585.57M8.70%445.66M6.73%317.55M63.60%166.47M17.20%543.02M38.84%409.98M67.43%297.53M49.68%101.76M
Total composite income of minority owners 29.09%86.63M8.55%37.58M13.31%134.77M9.76%92.33M16.17%67.11M79.53%34.62M15.64%118.94M14.13%84.12M34.31%57.77M27.06%19.28M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data